Australia markets closed

Cannara Biotech Inc. (8CB0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.4580+0.0240 (+5.53%)
As of 08:11AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
31/08/2019
Cash flows from operating activities
Net income
6,221
6,945
2,305
-1,528
-12,483
-
Depreciation & amortisation
5,668
4,942
3,921
3,026
2,583
-
Stock-based compensation
1,969
1,754
349.468
331.578
782.052
-
Change in working capital
-7,678
-6,113
-11,483
-3,820
-1,116
-
Accounts receivable
-3,235
-2,045
-5,675
-2,819
28.711
-
Inventory
-7,239
-8,328
-8,226
-3,367
-2,468
-
Other working capital
-186.874
-4,443
-21,546
-33,167
-18,640
-
Other non-cash items
1,821
-2,224
-658.978
-169.194
1,472
-
Net cash provided by operating activities
8,064
5,437
-6,079
-2,093
-9,325
-
Cash flows from investing activities
Investments in property, plant and equipment
-8,251
-9,879
-15,467
-31,074
-9,315
-
Net cash used for investing activities
-7,973
-9,478
-15,345
-30,829
-8,551
-
Cash flows from financing activities
Debt repayment
-2,187
-2,243
-34,300
-616.342
-6,563
-
Common stock issued
-
-
0
24,300
-
46,230
Common stock repurchased
-
-374.485
0
-
-
-
Dividends paid
0
0
0
0
0
-
Other financing activities
-306.47
-57.774
60,908
-171.364
-112.24
-
Net cash used provided by (used for) financing activities
-1,102
-3,719
25,464
33,252
-914.816
-
Net change in cash
-1,011
-7,760
4,040
329.675
-18,790
-
Cash at beginning of period
4,140
12,115
8,159
7,771
26,506
-
Cash at end of period
3,130
4,271
12,115
8,159
7,771
-
Free cash flow
Operating cash flow
8,064
5,437
-6,079
-2,093
-9,325
-
Capital expenditure
-8,251
-9,879
-15,467
-31,074
-9,315
-
Free cash flow
-186.874
-4,443
-21,546
-33,167
-18,640
-